Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Duloxetine
Drug ID BADD_D00734
Description Duloxetine is a dual serotonin and norepinephrine reuptake inhibitor.[label] It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686.[A178741] Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder.[L6454] It has since received approval for a variety of indications including the treatment of neuropathic pain, Generalized Anxiety disorder, osteoarthritis, and stress incontinence. Duloxetine continues to be investigated for the treatment of pain in cancer, surgery, and more.
Indications and Usage Authors unspecified: Duloxetine: new indication. Depression and diabetic neuropathy: too many adverse effects. Prescrire Int. 2006 Oct;15(85):168-72.
Marketing Status Prescription
ATC Code N06AX21
DrugBank ID DB00476
KEGG ID D07880
MeSH ID D000068736
PubChem ID 60835
TTD Drug ID D01AXB
NDC Product Code 55700-605; 60760-461; 53002-1561; 50436-0198; 71610-403; 47335-383; 70518-3287; 71205-005; 0228-2890; 43547-381; 61919-422; 53002-1494; 71205-358; 46708-279; 70710-1539; 68788-7672; 43547-379; 63629-5174; 80425-0119; 47335-616; 70710-1537; 55154-4981; 68180-294; 65841-801; 55154-4980; 45865-816; 70518-1128; 46708-278; 46708-280; 63629-8748; 47335-382; 70710-1538; 49252-007; 68382-386; 71205-602; 70771-1345; 68084-692; 61919-483; 50090-4011; 50090-4709; 51655-237; 67877-263; 47335-618; 71205-445; 70771-1344; 68382-387; 71335-2017; 68788-7935; 27241-099; 50268-288; 68180-296; 65841-799; 71335-1672; 70518-1011; 31722-168; 0228-2892; 63629-5202; 67877-265; 68180-295; 27241-164; 65977-0035; 47335-381; 70518-1054; 60760-462; 50090-5940; 47335-619; 68382-385; 31722-169; 50268-287; 45865-813; 68084-683; 63629-8051; 70771-1346; 65841-800; 43547-380; 49252-008; 71205-525; 68071-4700; 50090-4708; 55700-628; 70518-2855; 68180-297; 47335-617; 70518-3177; 31722-581; 70518-1139; 31722-582; 27241-098; 49252-009; 27241-097; 55700-727; 71335-0402; 67877-264; 68788-7828; 31722-583; 71335-1964; 68084-675; 0228-2891; 50436-0199; 50268-286; 31722-170; 70518-2630
Synonyms Duloxetine Hydrochloride | Hydrochloride, Duloxetine | Duloxetine HCl | HCl, Duloxetine | LY 248686 | LY-248686 | LY248686 | Duloxetine Ethanedioate (1:1), (+-)-isomer - T353987 | LY 227942 | LY-227942 | LY227942 | Duloxetine | N-methyl-3-(1-naphthalenyloxy)-3-(2-thiophene)propanamide | N-methyl-3-(1-naphthalenyloxy)-2-thiophenepropanamine | Duloxetine, (+)-isomer | Cymbalta
Chemical Information
Molecular Formula C18H19NOS
CAS Registry Number 116539-59-4
SMILES CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Cogwheel rigidity17.01.05.001; 15.05.04.0060.000132%Not Available
Cold sweat23.02.03.002; 08.01.03.0240.000728%Not Available
Colitis07.08.01.001--
Colitis ulcerative10.02.01.004; 07.08.01.005--Not Available
Coma17.02.09.001--Not Available
Completed suicide19.12.01.001; 08.04.01.0100.000535%Not Available
Confusional state19.13.01.001; 17.02.03.0050.093276%
Conjunctivitis11.01.06.012; 06.04.01.002--
Constipation07.02.02.001--
Conversion disorder19.24.01.0010.000198%Not Available
Convulsion neonatal18.04.04.003; 17.12.03.0170.000132%Not Available
Coordination abnormal17.02.02.0040.000529%Not Available
Coronary artery occlusion24.04.04.013; 02.02.01.0060.000132%Not Available
Cough22.02.03.001--
Creatinine renal clearance decreased13.13.01.0130.000331%Not Available
Crohn's disease07.08.01.015; 10.02.01.005--Not Available
Crying19.04.02.002; 17.02.05.013; 12.02.11.001; 08.01.03.0050.006748%Not Available
Deafness04.02.01.0010.000331%Not Available
Death08.04.01.001--
Decreased activity19.11.01.002; 08.01.01.0060.000132%Not Available
Decreased interest19.15.02.0040.000662%Not Available
Decubitus ulcer23.03.11.0060.000132%Not Available
Dehydration14.05.05.001--
Delirium19.13.02.0010.001389%
Delusion19.10.01.0010.000463%
Dementia19.20.02.001; 17.03.01.001--Not Available
Dementia Alzheimer's type19.20.03.001; 17.03.06.0010.000132%Not Available
Depressed level of consciousness17.02.04.0020.000926%
Depressed mood19.15.02.0010.004035%Not Available
Depression19.15.01.0010.018192%
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 26 Pages